T1	intervention 30 36	APF530
T2	control 44 56	palonosetron
T3	condition 78 118	chemotherapy-induced nausea and vomiting
T4	outcome-Measure 930 995	complete response (CR, no emesis or rescue medication) in cycle 1
T5	eligibility 134 216	patients with breast cancer receiving moderately or highly emetogenic chemotherapy
T6	No-of-participants 1031 1034	423
T7	No-of-participants 1044 1047	185
T8	outcome 1191 1215	CRs in cycle 1 for acute
T9	intervention-value 1236 1240	71 %
T10	intervention-value 1246 1250	77 %
T11	intervention-value 1264 1268	73 %
T12	intervention-value 1274 1278	73 %
T13	control-value 1408 1412	52 %
T14	control-value 1418 1422	52 %
T15	outcome 1424 1428	CINV
T16	outcome 1456 1487	differences in within-cycle CRs
